Related Experiment Video

Updated: Feb 13, 2026

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

428

Current standards for clinical management of small cell lung cancer

Anna F Farago1, Florence K Keane2

  • 1Cancer Center, Massachusetts General Hospital, Boston, MA, USA.

Translational Lung Cancer Research
|March 15, 2018
PubMed

Insights

Small cell lung cancer (SCLC) is an aggressive cancer with poor outcomes. This review examines current SCLC management strategies and supporting data, highlighting limited progress in treatment over three decades.

Area of Science:

  • Oncology
  • Pulmonology
  • Cancer Research

Background:

  • Small cell lung cancer (SCLC) is a high-grade neuroendocrine carcinoma.
  • SCLC is known for its aggressive nature and poor patient outcomes.
  • Despite extensive research, therapeutic advancements for SCLC have been minimal over the past 30 years.

Purpose of the Study:

  • To review the current clinical standards for managing SCLC.
  • To examine the evidence supporting existing SCLC treatment strategies.
  • To provide an overview of the current landscape of SCLC care.

Main Methods:

  • Literature review of clinical research and guidelines.
  • Analysis of data supporting current management strategies for SCLC.
  • Synthesis of information on SCLC treatment standards.

Main Results:

  • Current management of SCLC relies on established strategies.
  • The data supporting these strategies indicates limited recent progress.
  • Outcomes for SCLC patients remain unsatisfactory.

Conclusions:

  • There is a critical need for novel therapeutic approaches in SCLC.
  • Current treatment standards for SCLC require re-evaluation.
  • Further research is essential to improve SCLC patient survival and management.
Keywords:
Small cell lung cancer (SCLC)chemotherapyradiation

More Related Videos

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines09:45

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Published on: August 21, 2019

7.5K
Author Spotlight: Enhancing Multicolor Fluorescence Localization in Lung Carcinoma Sample05:00

Author Spotlight: Enhancing Multicolor Fluorescence Localization in Lung Carcinoma Sample

Published on: November 21, 2023

2.9K

Related Concept Videos

Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
746
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.1K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
605
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.3K
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
695
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
891